Currently out of the existing stock ratings of Jonathan Groberg, 5 are a HOLD (62.5%), 1 are a SELL (12.5%), 2 are a BUY (25%).

Jonathan Groberg

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Groberg, has had 83.33% of price targets met with an average potential upside of 26.46%, reached in 394 days on average. Previously, Jonathan Groberg worked at UBS.

Jonathan Groberg has documented 16 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on A, Agilent Technologies at 15-Feb-2017.

Wall Street Analyst Jonathan Groberg

Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) on 2/15/2017. The price target of $50 was fulfilled within 28 days with a profit of $2.02 (4.21%), with a performance score of 1.5.

Average potential price target upside

CRL Charles River Laboratories A Agilent Technologies BDX Becton Dickinson and Company ILMN Illumina

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Jul-2025

$400

$62.03 (18.35%)

$330

12 days ago
(05-Nov-2026)

11/12 (91.67%)

$73.71 (22.59%)

157

Buy Since 06-Aug-2026

$352

$14.03 (4.15%)

$322

12 days ago
(05-Nov-2026)

3/3 (100%)

$25.71 (7.88%)

12

Buy Since 06-Nov-2025

$375

$37.03 (10.96%)

$330

12 days ago
(05-Nov-2026)

14/15 (93.33%)

$48.71 (14.93%)

51

Buy Since 28-Sep-2026

$340

$2.03 (0.60%)

$195

1 months 20 days ago
(28-Sep-2026)

34/35 (97.14%)

$45.41 (15.41%)

227

Hold Since 07-Jun-2024

$295

$-42.97 (-12.71%)

$230

1 months 23 days ago
(25-Sep-2026)

11/11 (100%)

$2.16 (0.74%)

34

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?